Fda oks new weapon to battle resistant head lice

FDA OK’S NEW WEAPON TO BATTLE HEAD LICE
Cases of stubborn head lice spike during back-to-school time Suggested Date of Use: -- Tie in to back-to-school stories -- Head lice cases spike in the fall
To download broadcast-quality video and other SUGGESTED TEASE
STILL TO COME, WAGING WAR AGAINST HEAD LICE - WHY YOUR KIDS MAY BE MORE VULNERABLE THIS TIME OF YEAR - AND DETAILS ON A NEW WEAPON TO COMBAT THEM, NEXT. ANCHOR LEAD
IT’S ESTIMATED THERE ARE AS MANY AS 12-MILLION CASES OF HEAD LICE EACH YEAR IN THIS COUNTRY* - AND AS KIDS HEAD BACK TO SCHOOL CASES TEND TO SPIKE.
TO MAKE MATTERS WORSE, EXPERTS SAY HEAD LICE ARE GETTING HARDER TO TREAT.** BUT THE F-D-A HAS APPROVED A NEW OPTION IN THE BATTLE AGAINST HEAD LICE - WITH MORE, HERE’S CLARK POWELL.
(Nats - Laura and her kids playing board game) :02 CG: Courtesy: ParaPRO
WHAT’S FRUSTRATING TO MANY PARENTS IS THAT Pharmaceuticals
CASES OF HEAD LICE HAVE NOTHING TO DO WITH HYGIENE. YOUR KIDS CAN SHOWER AND SHAMPOO DAILY, BUT JUST ONE ENCOUNTER COULD MEAN WEEKS OF TREATMENTS - OFTEN METICULOUSLY COMBING OUT LICE AND THEIR EGGS- CALLED NITS- FOR HOURS AT A TIME. :16 CG: Laura Tanglertpaibul
“Probably 2-3 hours for one sitting. And we’d do that 3 times a Children had head lice
day. So, it takes up your whole life.” :08 CG: Tamra Munn
“Very difficult, because you don’t know - you can’t even tell what Child had head lice
EXPERTS SAY HEAD LICE ARE OFTEN HARD TO TREAT BECAUSE PARENTS MAY NOT USE MEDICINE PROPERLY, THEY REQUIRE METICULOUS NIT COMBING, OR - IN SOME CASES, THE LICE ARE RESISTANT TO THE MEDICINE. :10 BUT NOW PARENTS HAVE A NEW OPTION. THE F-D-A HAS APPROVED WHAT COULD BE A GAME CHANGING MEDICATION IN THE WAR AGAINST HEAD LICE- ONE THAT DOESN’T REQUIRE NIT COMBING TO BE EFFECTIVE.
IT’S CALLED NATROBA. IT IS A TOPICAL MEDICINE WHOSE ACTIVE INGREDIENT IS DERIVED FROM A NATURALLY OCCURRING SOIL MICROBE.*** IT IS APPROVED FOR KIDS 4 YEARS AND UP AND STUDIES SHOW IT’S ABOUT TWICE AS EFFECTIVE AS PERMETHRIN - THE MOST COMMONLY USED OVER THE COUNTER PRODUCT. :26 “Clinical studies really bore out the effectiveness // “The CG: Bob Haber, MD
numbers are very impressive with Natroba - at least twice as Dermatologist
effective as the most commonly used existing product.” :10 //1:15 - 1:21
Shots of Dr. Haber examining boy DOCTOR BOB HABER IS A DERMATOLOGIST WHO HELPED STUDY THE DRUG. HE SAYS THIS APPROACH IS AN EASY 3-STEP PROCESS. PARENTS APPLY THE MEDICINE, WAIT TEN MINUTES THEN RINSE IT OUT. A SECOND TREATMENT MAY BE NECESSARY IF LIVE LICE ARE SEEN AFTER ONE WEEK - BUT UNLIKE MANY TREATMENTS, NIT COMBING IS NOT REQUIRED.*** :19 Dr. Haber (CG’d earlier)
“So, applying a chemical to the scalp is relatively easy, but the hours and hours spent nit combing isn’t necessary with Natroba.” :08 THE BEST DEFENSE IS TO KEEP YOUR KIDS FROM GETTING HEAD LICE IN THE FIRST PLACE, BY: AVOIDING HEAD TO HEAD CONTACT - THIS IS THE MOST COMMON WAY LICE CAN SPREAD.
AND DON’T SHARE COMBS OR BRUSHES - OR EVEN THINGS LIKE HELMETS, HATS OR CAPS - IT ONLY TAKES A FEW SECONDS TO TRANSFER LICE FROM ONE HEAD TO ANOTHER. BUT DEALING WITH THEM CAN TAKE WEEKS. IN INDIANAPOLIS THIS IS CLARK POWELL REPORTING :24 ANCHOR TAG
IF YOUR CHILD DOES CONTRACT HEAD LICE EXPERTS SAY YOU SHOULD TALK TO YOUR DOCTOR.
THERE ARE OVER-THE-COUNTER MEDICINES AVAILABLE, BUT F-D-A APPROVED MEDICINES LIKE NATROBA ARE ONLY AVAILABLE WITH A PRESCRIPTION. NATROBA CONTAINS BENZYL ALCOHOL AND ISN’T RECOMMENDED FOR USE IN CHILDREN UNDER 6 MONTHS OF AGE.
NATROBA’S POSSIBLE SIDE EFFECTS MAY INCLUDE REDNESS AND IRRITATION IN THE EYES AND AT THE SITE OF APPLICATION.
VIEWER INFORMATION
For additional safety information, see the patient and full
prescribing information at *Head Lice, Centers for Disease Control and Prevention.
References -
*Therapy for Head Lice Based on Life Cycle, Resistance, and
Safety Considerations,
Pediatrics, Volume 119, Number 5, May
2007. Retrieved from:
References -
***Efficacy and Safety of Spinosad and Permethrin Creme Rinses
for Pediculosis Capitis (Head Lice
), Pediatrics, Volume 124
Volume 3,

Extra Bites
“They also lay eggs profusely. So one head louse can grow to hundreds and then thousands very, very quickly.” :07 “Head lice has nothing to do with hygiene, it has nothing to do with income, it has nothing to do with anything. If your child happens to come close - head to head contact with another child CG: Robert Haber, MD
with head lice, the head lice are very happy to jump ship and find Dermatologist
“Nit combing with tiny combs, or with your finger nails, can take hours and hours and hours. And again, if you miss one egg, that’s all it takes. The little fellow hatches, and the whole process starts all over again.” :11 CG: Laura Tanglertpaibul
“She scratched her head and went ‘Mom, what’s this?’. And it Children had head lice
was a little bug and I thought Oh, my gosh.” :20 “It was just picking the nits out one by one that did it. Because nothing seemed to kill the bugs and the eggs.” :09 CG: Tamra Munn
“It takes forever. You have to comb the hair, which takes about 2 Child had head lice
hours and you have to do it twice a day.” :09 “You want to make sure you get every little tiny thing out of every strand of hair. And you have to go through almost 4 or 5 hairs at a time.” :10 Producers:
Extra b-roll is included. To download scripts, video and
support material visit us at:
For viewer information on this story contact:
Phone: (614) 932-9950 Fax: (614) 932-9920 Video content provided by:
Media Relations Department:

Source: http://njhealth.multimedianewsroom.tv/newmedia//mcp/triad_old/headlice/1-Documents/Natroba_Script.pdf

ffessm.cd84.free.fr

CODEP 84 - Comité Directeur du 17 Septembre 2013 Espace Acampado – Piolenc Présents : BERTRAND Philippe Excusés : GIRAUD Karine Le Président Marc LE MEZO ouvre la séance à 19h20 selon l’ordre du jour : 1/ PRESIDENT - Marc LE MEZO - 25 Juil et : Journée Mer avec les jeunes du centre de loisir de PIOLENC. Remerciements à Messieurs Patrick CHABERT, Jean-Cha

Microsoft word - antares oxybutynin gel approval final clean

NEWS RELEASE Antares’ Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder -- Novel Formulation Provides Convenience, Efficacy and Excellent Tolerability -- Watson to Launch Product in Spring 2012 -- PARSIPPANY, NJ and EWING, NJ – December 8, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) and Antares Pharma, Inc. (NYSE Amex: AIS) today ann

Copyright © 2008-2018 All About Drugs